financetom
Business
financetom
/
Business
/
Grupo Aeroportuario del Pacifico Issues $283.8 Million in Bonds
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Grupo Aeroportuario del Pacifico Issues $283.8 Million in Bonds
Sep 6, 2024 1:24 PM

04:08 AM EDT, 09/06/2024 (MT Newswires) -- Grupo Aeroportuario del Pacifico (PAC) said Thursday that it issued about 56.5 million long-term bond certificates in Mexico with a five-year maturity at a nominal value of 100 pesos ($5.02) for a total value of about 5.65 billion pesos.

The company said the order book reached an over-subscription of 1.2 times over the original amount.

The proceeds from the bond issuance will be used to pay down other debt, fulfill committed capital investments, and make commercial investments.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US SEC case over massive Allen Stanford fraud ends, judge orders fines
US SEC case over massive Allen Stanford fraud ends, judge orders fines
Jan 30, 2025
* Convicted financier ordered to pay $5.9 billion fine * Fake CDs used in Ponzi scheme * Stanford serving 110-year prison term By Jonathan Stempel Jan 30 (Reuters) - A federal judge ordered an end to the U.S. Securities and Exchange Commission's 16-year-old lawsuit over Allen Stanford's $7.2 billion Ponzi scheme, directing the financier and two former colleagues to pay...
Alterity Therapeutics Says ATH434 Showed Slowing of Clinical Progression in Phase 2 Multiple System Atrophy Study; Shares Up
Alterity Therapeutics Says ATH434 Showed Slowing of Clinical Progression in Phase 2 Multiple System Atrophy Study; Shares Up
Jan 30, 2025
09:39 AM EST, 01/30/2025 (MT Newswires) -- Alterity Therapeutics ( ATHE ) shares were sharply higher Thursday morning after the company said that its ATH434 lead candidate demonstrated 48% slowing of clinical progression in a phase 2 clinical trial in patients with early-stage multiple system atrophy. The result was achieved at the 50 mg dose at week 52 when compared...
UniQure Gets Favorable Recommendation From Data Monitoring Committee AMT-162 Trial to Treat Amyotrophic Lateral Sclerosis
UniQure Gets Favorable Recommendation From Data Monitoring Committee AMT-162 Trial to Treat Amyotrophic Lateral Sclerosis
Jan 30, 2025
09:47 AM EST, 01/30/2025 (MT Newswires) -- UniQure ( QURE ) said Thursday the Independent Data Monitoring Committee for a phase 1/2 trial of AMT-162 to treat amyotrophic lateral sclerosis caused by mutations in the superoxide dismutase 1 gene recommended going ahead with enrollment in the second group after reviewing safety data from the first group in the study. The...
Dover Delivers Strong Q4 Margins & EPS Beat, Stock Climbs On 2025 Optimism
Dover Delivers Strong Q4 Margins & EPS Beat, Stock Climbs On 2025 Optimism
Jan 30, 2025
Dover Corporation ( DOV ) shares are trading higher on Thursday after the company reported fourth-quarter results. Revenue stood at $1.93 billion, an increase of 1% year-over-year, missing the consensus of $1.95 billion.  Segment earnings margin expanded 50 bps Y/Y to 22.2%. Total adjusted segment EBITDA margin expanded to 24.2% from 23.5% a year ago. Margin improved aided by favourable mix from the high margin, high growth platforms, and strict...
Copyright 2023-2026 - www.financetom.com All Rights Reserved